Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacyclics starts phase III Gd-Tex trial for brain metastases

Sep. 28, 1998

Polish researchers present new antitumor agents

Sep. 28, 1998

Investigators at C&C Research design new antiestrogenic agents

Sep. 28, 1998

HMR grants Matrix rights to anticancer agent about to enter phase II

Sep. 25, 1998

Oxigene updates Neu-Sensamide development status

Sep. 25, 1998

Biomira and Biovector collaborate on development of idiotypic B-cell lymphoma vaccine

Sep. 24, 1998

New paclitaxel formulation enters clinical trials

Sep. 24, 1998

Another series of DC-107 derivatives from Kyowa Hakko particularly useful as antitumor agents

Sep. 24, 1998

Hydroxamic acids as cancer cell differentiation inducers under study at Mitsui Chemicals

Sep. 24, 1998

Expanded approval requested for chemoprotective agent

Sep. 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...